• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the structural elucidation of oxidized product of 8-methoxypsoralen

Research Project

Project/Area Number 62570458
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Dermatology
Research InstitutionNagoya City University

Principal Investigator

MIZUNO Nobuyuki  Professor, Nagoya City University Medical School, 医学部, 教授 (10079973)

Co-Investigator(Kenkyū-buntansha) NAGAI Shinichi  Assistant,, 薬学部, 助手 (40080212)
SAKAKIBARA Jinsaku  Professor, Faculty of Pharmaceutical Sciences, 薬学部, 教授 (70080182)
ESAKI Kenji  Assistant, Nagoya City University Medical School, 医学部, 助手 (90137109)
Project Period (FY) 1987 – 1988
Project Status Completed (Fiscal Year 1988)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1988: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1987: ¥1,000,000 (Direct Cost: ¥1,000,000)
KeywordsChemical structure of oxidized 8-methoxypsoralen / Inhibition of anaphylatoxin C5a activity / Chemotactic activity of neutrophiles / 免疫複合体病の治療 / 8ーメトキシソラレン酸化物の化学構造 / 8ーメトキシソラレン / アナフィラトキシンC5a / 好中球遊走能抑制 / ソラレン酸化物 / アテフィラトキシン / 白血球遊走能制御
Research Abstract

Treatment of anaphylatoxin C5a with 8-methoxypsoralen (8MOP) plus UVA inhibits the chemotaxis of polymorphonuclear neutrophiles (PMN) towards C5a. The mechanism of this reaction is considered as follows: 8MOP ^18MOP ^38MOP (1) ^38MOP+^3O_2 8MOP+^1O_2 oxidized product of 8MOP(8MOP-O_2) (2) 8MOP-O_2+C5a C5a 8MOP-O_2 conjugation ? (3) inactivation of C5a
Biological activity of 8MOP-O_2 persists for 2 weeks at room temperature. We determined the chemical structure of this bioactive 8MOP-O_2. It could be applied for the treatment of immune complex diseases as well as neutrophile-amplified dermatoses.
Several fractions of 8MOP-O_2 made with H_2O_2-NaOCl were separated by TLC and HPLC. Number of PMN migrated towards the mixture of C5a des Arg and each fraction was measured with blind well chamber. Bioactive fraction was obtained as a single compound. Its mass spectrum showed 264 (C_<13>H_<12>O_6, M^+). The structural elucidation was determined by infrared spectrum, ^1H NMR and ^<13>C NMR to be 2, 3-dihydro-2, 9, -dimethoxy-3-hydroxy-7-oxo-7H-furo [3, 2-g][1]benzopyran.

Report

(3 results)
  • 1988 Annual Research Report   Final Research Report Summary
  • 1987 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Nobuyuki Muzuno.: Proc.Jpn.Soc.Invest.Dermatol.11. 63-64 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] 水野信行: 医学のあゆみ. 140. 482-484 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Nobuyuki Muzuno.: J.Invest.Dermatol.92. (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Nobuyuki Mizuno: "Treatment of immune complex diseases with photooxidation product of psoralen" Proc. Jpn. Soc. Invest. Dermatol.11. 63-64 (1987)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Nobuyuki Mizuno: "Treatment of immune complex diseases with photooxidized product of psoralen - PUVA treatment" Igakuno ayumi. 140. 482-484 (1987)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Nobuyuki Mizuno: "Structural elucidation of oxidized product of 8-methoxypsoralen to inhibit the chemotactic activity of anaphylatoxin C5a" J. Invest. Dermatol.92. (1989)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1988 Final Research Report Summary
  • [Publications] Nobuyuki Mizuno: J.Invest.Dermatol.92. (1989)

    • Related Report
      1988 Annual Research Report

URL: 

Published: 1987-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi